American Association for the Advancement of Science, Science Translational Medicine, 533(12), 2020
DOI: 10.1126/scitranslmed.aaz0152
Full text: Unavailable
IDC-P and ductal adenocarcinoma are two pathologies that can indicate aggressive primary prostate cancer.